There is no content matching your selection.
Featured Article
https://doi.org/10.12688/f1000research.141719.1
Editorial
metrics
NOT PEER REVIEWED
Michael S. Biddle,
Harvinder S. Virk
- Funders
-
Medical Research Council
-
Leicester Institute of Advanced Studies
PUBLISHED 16 Oct 2023
https://doi.org/10.12688/f1000research.184178.1
Data Note
metrics
AWAITING PEER REVIEW
Riham Ayoubi,
Charles Alende,
Maryam Fothouhi,
Sara González Bolívar,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme,
NeuroSGC/YCharOS/EDDU collaborative group
Peer Reviewers
Invited
- Funders
-
Structural Genomics Consortium
-
Thank you to the Structural Genomics Consortium, a registered charity (no. 1097737), for your support on this project. The Structural Genomics Consortium receives funding from Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Genome Canada through Ontario Genomics Institute (grant no. OGI196), the EU and EFPIA through the Innovative Medicines Initiative 2 Joint Undertaking (EUbOPEN grant no. 875510), Janssen, Merck KGaA (also known as EMD in Canada and the United States), Pfizer and Takeda.
-
Genome Canada
PUBLISHED 30 Jun 2026
https://doi.org/10.12688/f1000research.183125.1
Data Note
metrics
AWAITING PEER REVIEW
Vera Ruíz Moleón,
Charles Alende,
Maryam Fothouhi,
Sara González Bolívar,
Riham Ayoubi,
Vincent Francis,
Peter S McPherson,
Carl Laflamme
Peer Reviewers
Invited
- Funders
-
This work was supported in part by the Emory-Sage-SGC TaRget Enablement to Accelerate Therapy Development for Alzheimer’s Disease (TREAT-AD) center established by the National Institute on Aging (grant no. U54AG065187). This work was also supported by a grant from the Quebec Consortium for Drug Discovery (CQDM), a grant from the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
-
Michael J. Fox Foundation for Parkinson's Research
-
TREAT-AD
-
Québec Consortium for Drug Discovery
PUBLISHED 26 Jun 2026
https://doi.org/10.12688/f1000research.182633.1
Data Note
metrics
AWAITING PEER REVIEW
CongYao Zha,
Charles Alende,
Maryam Fotouhi,
Sara González Bolívar,
Riham Ayoubi,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme
Peer Reviewers
Invited
- Funders
-
Michael J. Fox Foundation for Parkinson's Research
-
This work was supported by the Michael J. Fox Foundation for Parkinson’s Research (MJFF) (grant no. 18331). This work was also supported by a grant from the Quebec Consortium for Drug Discovery (CQDM), a grant from the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
-
Québec Consortium for Drug Discovery
PUBLISHED 23 Jun 2026
https://doi.org/10.12688/f1000research.182354.1
Data Note
metrics
AWAITING PEER REVIEW
Vera Ruíz Moleón,
Charles Alende,
Maryam Fothouhi,
Sara González Bolívar,
Riham Ayoubi,
Vincent Francis,
Peter S McPherson,
Carl Laflamme
Peer Reviewers
Invited
- Funders
-
This research was partly funded by the G-Can (GBA1-Canada) initiative, an open-science collaboration dedicated to advancing research on Parkinson's disease associated with GBA1 mutations. G-Can is supported by The Hilary & Galen Weston Foundation, Silverstein Foundation, and J. Sebastian van Berkom and Ghislaine Saucier. This work was also supported by the CQDM (by a grant from the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec) and by the Government of Canada through Genome Canada, Genome Quebec, and Ontario Genomics (grant no. OGI-210).
-
Genome Canada
PUBLISHED 16 Jun 2026
https://doi.org/10.12688/f1000research.178929.1
Data Note
metrics
Riham Ayoubi,
Charles Alende,
Vera Ruíz Moleón,
Maryam Fothouhi,
Sara González Bolívar,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme,
NeuroSGC/YCharOS/EDDU Collaborative Group
Peer Reviewers
Jieya Shao;
Deborah Moshinsky
- Funders
-
Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec
-
The Hilary & Galen Weston Foundation, Silverstein Foundation, and J. Sebastian van Berkom and Ghislaine Saucier
PUBLISHED 30 Apr 2026
https://doi.org/10.12688/f1000research.178749.1
Data Note
metrics
AWAITING PEER REVIEW
Vera Ruíz Moleón,
Charles Alende,
Maryam Fothouhi,
Sara González Bolívar,
Vincent Francis,
Riham Ayoubi,
Peter S. McPherson,
Carl Laflamme
Peer Reviewers
Invited
- Funders
-
G-Can (GBA1-Canada) initiative
-
CQDM (by a grant from the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec)
PUBLISHED 28 Apr 2026
https://doi.org/10.12688/f1000research.179398.1
Data Note
metrics
AWAITING PEER REVIEW
Vera Ruíz Moleón,
Sara González Bolívar,
Riham Ayoubi,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme
Peer Reviewers
Invited
- Funder
-
This work was supported by the Terry Fox Foundation for Cancer Research (grant no. 1190-09). This work was also supported by a grant from the Quebec Consortium for Drug Discovery (CQDM), a grant from the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PUBLISHED 28 Apr 2026
https://doi.org/10.12688/f1000research.179396.1
Data Note
metrics
AWAITING PEER REVIEW
Vera Ruíz Moleón,
Charles Alende,
Maryam Fothouhi,
Sara González Bolívar,
Riham Ayoubi,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme
Peer Reviewers
Invited
- Funder
-
This work was supported by the Terry Fox Foundation for Cancer Research (grant no. 1190-09). This work was also supported by a grant from the Quebec Consortium for Drug Discovery (CQDM), a grant from the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PUBLISHED 28 Apr 2026
https://doi.org/10.12688/f1000research.179367.1
Data Note
metrics
Vera Ruíz Moleón,
Charles Alende,
Maryam Fothouhi,
Sara González Bolívar,
Riham Ayoubi,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme
Peer Reviewers
Karen Bowman;
Deborah Moshinsky
- Funder
-
This work was supported by the Terry Fox Foundation for Cancer Research (grant no. 1190-09). This work was also supported by a grant from the Quebec Consortium for Drug Discovery (CQDM), a grant from the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PUBLISHED 24 Apr 2026
https://doi.org/10.12688/f1000research.175973.1
Data Note
metrics
Michael Biddle,
Jemma Cooper,
Carolyn Jones,
Katie Dixon,
Harvinder Virk
Peer Reviewers
Jieya Shao;
Christian Tiede
- Funders
-
Medical Research Council
-
National Centre for the Replacement Refinement and Reduction of Animals in Research
PUBLISHED 19 Jan 2026
https://doi.org/10.12688/f1000research.175969.1
Data Note
metrics
Jemma Cooper,
Carolyn Jones,
Katie Dixon,
Bibek Gooptu,
Harvinder Virk,
Michael Biddle
Peer Reviewers
Steve Jean;
Sian E. Evans
- Funders
-
National Centre for the Replacement, Refinement and Reduction of Animals in Research
-
Medical Research Council
PUBLISHED 19 Jan 2026
https://doi.org/10.12688/f1000research.174230.1
Data Note
metrics
Donovan Worrall,
Charles Alende,
Maryam Fothouhi,
Vera Ruíz Moleón,
Sara González Bolívar,
Riham Ayoubi,
Vincent Francis,
Carl Laflamme,
Peter S. McPherson
Peer Reviewers
Deborah Moshinsky;
Karen Bowman
- Funders
-
Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec
-
The Hilary & Galen Weston Foundation, Silverstein Foundation, and J. Sebastian van Berkom and Ghislaine Saucier
PUBLISHED 15 Dec 2025
https://doi.org/10.12688/f1000research.170886.1
Data Note
metrics
Vera Ruíz Moleón,
Riham Ayoubi,
Charles Alende,
Maryam Fothouhi,
Joel Ryan,
Sara González Bolívar,
Donovan Worrall,
Thomas M Durcan,
Claire M Brown,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme
Peer Reviewers
Deborah Moshinsky;
Sian E. Evans
- Funder
-
ALS-Reproducible Antibody Platform (ALS-RAP)
PUBLISHED 23 Oct 2025
https://doi.org/10.12688/f1000research.169966.1
Data Note
metrics
Vera Ruíz Moleón,
Riham Ayoubi,
Charles Alende,
Maryam Fothouhi,
Joel Ryan,
Sara González Bolívar,
Donovan Worrall,
Thomas M Durcan,
Claire M Brown,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme
Peer Reviewers
Deborah Moshinsky;
Andrew Buchanan
- Funders
-
ALS Society of Canada
-
ALS Association
-
Motor Neurone Disease Association
-
Québec Consortium for Drug Discovery
PUBLISHED 17 Oct 2025
https://doi.org/10.12688/f1000research.169502.1
Data Note
metrics
Vera Ruíz Moleón,
Maryam Fotouhi,
Joel Ryan,
Donovan Worrall,
Riham Ayoubi,
Vincent Francis,
Peter S. McPherson,
Carl Laflamme
Peer Reviewers
Deborah Moshinsky;
Karen Bowman
- Funders
-
ALS Society of Canada
-
ALS Association
-
Motor Neurone Disease Association
-
Mitacs
-
Québec Consortium for Drug Discovery
PUBLISHED 09 Sep 2025
https://doi.org/10.12688/f1000research.160217.2
Data Note
metrics
Vera Ruíz Moleón,
Charles Alende,
Maryam Fotouhi,
Sara González Bolívar,
Riham Ayoubi,
Carl Laflamme,
NeuroSGC/YCharOS/EDDU collaborative group,
ABIF consortium
Peer Reviewers
Cecilia Williams and Matilda Holm;
Michael L. Garelja;
Deborah Moshinsky
- Funders
-
Ontario Genomics
-
Michael J. Fox Foundation for Parkinson's Research
-
Génome Québec
-
Mitacs
-
Genome Canada
LATEST VERSION PUBLISHED 13 Jun 2025
https://doi.org/10.12688/f1000research.143928.3
Data Note
metrics
Vera Ruíz Moleón,
Charles Alende,
Maryam Fotouhi,
Riham Ayoubi,
Sara González Bolívar,
Kathleen Southern,
Peter S. McPherson,
Carl Laflamme,
NeuroSGC/YCharOS/EDDU collaborative group,
ABIF consortium
Peer Reviewers
Shinsuke Niwa;
Claudia Fallini
- Funders
-
Ontario Genomics
-
Canadian Institutes of Health Research Foundation
-
Mitacs
-
Genome Québec
-
Genome Canada
LATEST VERSION PUBLISHED 07 Mar 2025
https://doi.org/10.12688/f1000research.153244.3
Data Note
metrics
Riham Ayoubi,
Maryam Fotouhi,
Charles Alende,
Sara González Bolívar,
Kathleen Southern,
Carl Laflamme,
NeuroSGC/YCharOS/EDDU collaborative group,
ABIF consortium
Peer Reviewers
Melissa Pitman;
Christian Tiede;
Jieya Shao
- Funders
-
Ontario Genomics
-
Mitacs
-
Genome Quebec
-
Emory-Sage-SGC TaRget Enablement to Accelerate Therapy Development for Alzheimer’s Disease
-
Genome Canada
-
National Institute on Aging
LATEST VERSION PUBLISHED 24 Jan 2025
https://doi.org/10.12688/f1000research.160371.1
Data Note
metrics
Vera Ruíz Moleón,
Charles Alende,
Maryam Fotouhi,
Riham Ayoubi,
Carl Laflamme,
NeuroSGC/YCharOS/EDDU collaborative group,
ABIF consortium
Peer Reviewers
Deborah Moshinsky;
Sian E. Evans and Carolyn Jones
- Funders
-
Ontario Genomics
-
ALS Society of Canada
-
Génome Québec
-
ALS Association
-
Motor Neurone Disease Association
-
Mitacs
-
Genome Canada
PUBLISHED 06 Jan 2025
https://doi.org/10.12688/f1000research.155929.2
Data Note
metrics
Vera Ruíz Moleón,
Charles Alende,
Maryam Fotouhi,
Riham Ayoubi,
Kathleen Southern,
Carl Laflamme,
NeuroSGC/YCharOS/EDDU collaborative group,
ABIF consortium
Peer Reviewers
Karen Bowman;
Jieya Shao;
Sheng-ce Tao;
Mathias Nielsen and John LaCava
- Funders
-
Ontario Genomics
-
Michael J. Fox Foundation for Parkinson’s Disease Research
-
Genome Quebec
-
Mitacs
-
Genome Canada
LATEST VERSION PUBLISHED 02 Jan 2025